Activation and repression of p21WAF1/CIP1 transcription by RB binding proteins

被引:0
|
作者
Andrei L Gartel
Eugene Goufman
Sergei G Tevosian
Heather Shih
Amy S Yee
Angela L Tyner
机构
[1] University of Illinois at Chicago,Department of Molecular Genetics
[2] 900 S.,Department of Biochemistry
[3] Tufts University School of Medicine,undefined
来源
Oncogene | 1998年 / 17卷
关键词
p21; E2F; HBP1; Sp1;
D O I
暂无
中图分类号
学科分类号
摘要
The Cdk inhibitor p21WAF1/CIP1 is a negative regulator of the cell cycle, although its expression is induced by a number of mitogens that promote cell proliferation. We have found that E2F1 and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the p21 promoter. In contrast, HBP1 (HMG-box protein-1), a novel retinoblastoma protein-binding protein, can repress the p21 promoter and inhibit induction of p21 expression by E2F. Both E2Fs and HBP1 regulate p21 transcription through cis-acting elements located between nucleotides −119 to +16 of the p21 promoter and the DNA binding domains of each of these proteins are required for activity. Sequences between −119 and −60 basepairs containing four Sp1 consensus elements and two noncanonical E2F binding sites are of major importance for E2F activation, although E2F1 and E2F3 differ in the extent of their ability to activate expression when this segment is deleted. The opposing effects of E2Fs and HBP1 on p21 promoter activity suggest that interplay between these factors may determine the level of p21 transcription in vivo.
引用
收藏
页码:3463 / 3469
页数:6
相关论文
共 50 条
  • [21] p21Waf1/Cip1 deficiency stimulates centriole overduplication
    Duensing, Anette
    Ghanem, Louis
    Steinman, Richard A.
    Liu, Ying
    Duensing, Stefan
    CELL CYCLE, 2006, 5 (24) : 2899 - 2902
  • [22] Transcriptional activation of p21waf1/cip1 by alkylphospholipids:: Role of the mitogen-activated protein kinase pathway in the transactivation of the human p21waf1/cip1 promoter by Sp1
    De Siervi, A
    Marinissen, M
    Diggs, J
    Wang, XF
    Pages, G
    Senderowicz, A
    CANCER RESEARCH, 2004, 64 (02) : 743 - 750
  • [23] Not Just a CDK Inhibitor: Regulation of Transcription by p21WAF1/CIP1/SDI1
    Perkins, Neil D.
    CELL CYCLE, 2002, 1 (01) : 39 - 41
  • [24] p21Waf1/Cip1 Polymorphisms and Risk of Esophageal Cancer
    Wenjun Yang
    Qi Qi
    Heng Zhang
    Wenda Xu
    Zhiqiang Chen
    Li Wang
    Yin Wang
    Xiaowei Dong
    Haiyan Jiao
    Zhenghao Huo
    Annals of Surgical Oncology, 2010, 17 : 1453 - 1458
  • [25] p21WAF1/CIP1 acts as a brake in osteoblast differentiation
    Bellosta, P
    Masramon, L
    Mansukhani, A
    Basilico, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (05) : 818 - 826
  • [26] Expression, Purification and Spectral Characterization of p21Waf1/Cip1
    SHI Qiao-yun1
    2. Department of Central Laboratory
    ChemicalResearchinChineseUniversities, 2008, (02) : 192 - 195
  • [27] p21WAF1/CIP1与乳腺癌
    马双慰
    国外医学(生理、病理科学与临床分册), 2001, (06) : 493 - 495
  • [28] p53 and p21WAF1/CIP1 proteins and cells proliferation in ovarian carcinomas
    不详
    EJC SUPPLEMENTS, 2006, 4 (01): : 50 - 50
  • [29] Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1 -: Ets-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF1/Cip1 promoter
    Zhang, CL
    Kavurma, MM
    Lai, A
    Khachigian, LM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) : 27903 - 27909
  • [30] Targeted p21WAF1/CIP1 Activation by RNAa Inhibits Hepatocellular Carcinoma Cells
    Kosaka, Mika
    Kang, Moo Rim
    Yang, Glen
    Li, Long-Cheng
    NUCLEIC ACID THERAPEUTICS, 2012, 22 (05) : 335 - 343